Current Report Filing (8-k)
September 23 2020 - 12:13PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): September 23, 2020
Blonder
Tongue Laboratories, Inc.
(Exact
Name of registrant as specified in its charter)
Delaware
|
|
1-14120
|
|
52-1611421
|
(State
or other jurisdiction
of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S.
Employer
Identification No.)
|
One
Jake Brown Road, Old Bridge, New Jersey 08857
(Address
of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code: (732) 679-4000
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
symbol(s)
|
|
Name
of each exchange on which registered
|
Common
Stock, par value $.001
|
|
BDR
|
|
NYSE
American
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
|
Item
7.01
|
Regulation
FD Disclosure.
|
On
September 23, 2020, Blonder Tongue Laboratories, Inc. (the “Company”) issued a press release regarding the Company’s
receipt of a patent for certain technologies within its NeXgen Gateway (NXG) video delivery platform.
A copy of the press release
is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
The
information in this Item 7.01, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under
that Section, and shall not be deemed incorporated by reference into any of the Company’s reports or filings under the Securities
Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as expressly set forth by specific
reference in such report or filing. The inclusion of this Item 7.01 in this Current Report on Form 8-K, including Exhibit 99.1
attached hereto, shall not be deemed an admission as to the materiality of any information herein.
|
Item
9.01
|
Financial
Statements and Exhibits
|
|
(d)
|
Exhibits.
The following exhibits are filed herewith:
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
BLONDER TONGUE LABORATORIES, INC.
|
|
|
|
|
By:
|
/s/
Eric Skolnik
|
|
|
Eric
Skolnik
|
|
|
Senior
Vice President and Chief Financial Officer
|
Date:
September 23, 2020
2
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Blonder Tongue Laborator... (AMEX:BDR)
Historical Stock Chart
From Apr 2023 to Apr 2024